RecruitingPhase 2NCT07041281

Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Intervention
spironolactone 25 mg orally once daily(drug)
Enrollment
204 target
Eligibility
18 years · FEMALE
Timeline
20252029

Study locations (3)

Collaborators

Brigham and Women's Hospital · University of Pittsburgh Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07041281 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials